Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort

References

• Jankowich MD, Rounds S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung. 2010;188(5):365–373. doi:10.1007/s00408-010-9251-6
   PubMed Web of Science ®Google Scholar
• Auerbach O, Garfinkel L, Hammond EC. Relation of smoking and age to findings in lung parenchyma: a Microscopic Study. Chest. 1974;65(1):29–35. doi:10.1378/chest.65.1.29
   PubMed Web of Science ®Google Scholar
• Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol. 2010;41(3):316–325. doi:10.1016/j.humpath.2009.09.003
   PubMed Web of Science ®Google Scholar
• Keller CA, Naunheim KS, Osterloh J, Espiritu J, McDonald JW, Ramos RR. Histopathologic diagnosis made in lung tissue resected from patients with severe emphysema undergoing lung volume reduction surgery. Chest. 1997;111(4):941–947. doi:10.1378/chest.111.4.941
   PubMed Web of Science ®Google Scholar
• Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med. 1990;84(5):365–369. doi:10.1016/S0954-6111(08)80070-4
   PubMed Web of Science ®Google Scholar
• Lim TK. Respiratory failure from combined emphysema and pulmonary fibrosis. Singapore Med J. 1993;34(2):169–171.
   PubMedGoogle Scholar
• Cottin V, Cordier JF. The syndrome of combined pulmonary fibrosis and emphysema. Chest. 2009;136(1):1–2. doi:10.1378/chest.09-0538
   PubMed Web of Science ®Google Scholar
• Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26(4):586–593. doi:10.1183/09031936.05.00021005
   PubMed Web of Science ®Google Scholar
• Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(4):431–440. doi:10.1164/rccm.201006-0894CI
   PubMed Web of Science ®Google Scholar
• Mejia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009;136(1):10–15. doi:10.1378/chest.08-2306
   PubMed Web of Science ®Google Scholar
• Sato S, Koike T, Hashimoto T, et al. Surgical outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema and those with idiopathic pulmonary fibrosis without emphysema. Ann Thorac Cardiovasc Surg. 2016;22(4):216–223. doi:10.5761/atcs.oa.15-00315
   PubMed Web of Science ®Google Scholar
• Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med. 2009;103(8):1209–1215. doi:10.1016/j.rmed.2009.02.001
   PubMed Web of Science ®Google Scholar
• Ciccarese F, Attina D, Zompatori M. Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know. Radiol Med. 2016;121(7):564–572. doi:10.1007/s11547-016-0627-4
   PubMed Web of Science ®Google Scholar
• Watadani T, Sakai F, Johkoh T, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology. 2013;266(3):936–944. doi:10.1148/radiol.12112516
   PubMed Web of Science ®Google Scholar
• Inomata M, Ikushima S, Awano N, et al. An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features. BMC Pulm Med. 2014;14(1):104. doi:10.1186/1471-2466-14-104
   PubMedGoogle Scholar
• Lai RS, Chen CF, Chu KA, Lin MH. The effect of emphysema on survival in patients with idiopathic pulmonary fibrosis: a retrospective study in Taiwan. J Chin Med Assoc. 2019;82(12):922–928. doi:10.1097/JCMA.0000000000000201
   PubMed Web of Science ®Google Scholar
• Prevention WVDoT. Addressing Tobacco Use and Its Associated Health Conditions in West Virginia. Promotion OoCHSaH, editor. 2016.
   Google Scholar
• Cottin V. Combined pulmonary fibrosis and emphysema: bad and ugly all the same? Eur Respir J. 2017;50(1):1700846. doi:10.1183/13993003.00846-2017
   PubMed Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44–e68. doi:10.1164/rccm.201807-1255ST
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Shen Y, Wan C, Tian P, et al. CT-base pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review. Medicine (Baltimore). 2014;93(27):e256. doi:10.1097/MD.0000000000000256
   PubMedGoogle Scholar
• Cottin V. The impact of emphysema in pulmonary fibrosis. Eur Respir Rev. 2013;22(128):153–157. doi:10.1183/09059180.00000813
   PubMedGoogle Scholar
• Lin H, Jiang S. Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone. J Thorac Dis. 2015;7(4):767–779. doi:10.3978/j.issn.2072-1439.2015.04.17
   PubMed Web of Science ®Google Scholar
• Jankowich MD, Rounds SIS. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest. 2012;141(1):222–231. doi:10.1378/chest.11-1062
   PubMed Web of Science ®Google Scholar
• Nguyen KH, Marshall L, Brown S, Neff L. State-specific prevalence of current cigarette smoking and smokeless tobacco use among adults - United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(39):1045–1051. doi:10.15585/mmwr.mm6539a1
   PubMed Web of Science ®Google Scholar
• Hoyer N, Prior TS, Bendstrup E, Wilcke T, Shaker SB. Risk factors for diagnostic delay in idiopathic pulmonary fibrosis. Respir Res. 2019;20(1):103. doi:10.1186/s12931-019-1076-0
   PubMed Web of Science ®Google Scholar
• Buendia-Roldan I, Mejia M, Navarro C, Selman M. Idiopathic pulmonary fibrosis: clinical behavior and aging associated comorbidities. Respir Med. 2017;129:46–52. doi:10.1016/j.rmed.2017.06.001
   PubMed Web of Science ®Google Scholar
• Caminati A, Lonati C, Cassandro R, et al. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respir Rev. 2019;28:153. doi:10.1183/16000617.0044-2019
   Web of Science ®Google Scholar
• Cottin V, Le Pavec J, Prevot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 2010;35(1):105–111. doi:10.1183/09031936.00038709
   PubMed Web of Science ®Google Scholar
• Amariei DE, Dodia N, Deepak J, et al. Combined pulmonary fibrosis and emphysema: pulmonary function testing and a pathophysiology perspective. Medicina (Kaunas). 2019;55(9). doi:10.3390/medicina55090580
   PubMed Web of Science ®Google Scholar
• Jacob J, Bartholmai BJ, Rajagopalan S, et al. Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis. Eur Respir J. 2017;50(1). doi:10.1183/13993003.00379-2017
   PubMed Web of Science ®Google Scholar
• Maher TM, Strek ME. Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respir Res. 2019;20(1):205. doi:10.1186/s12931-019-1161-4
   PubMed Web of Science ®Google Scholar
• Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(6):524–526. doi:10.1513/pats.200904-016DS
   PubMedGoogle Scholar
• Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155(1):242–248. doi:10.1164/ajrccm.155.1.9001319
   PubMed Web of Science ®Google Scholar
• Park Y, Ahn C, Kim T-Y. Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses. Sci Rep. 2021;11(1):4318. doi:10.1038/s41598-021-81591-z
   PubMed Web of Science ®Google Scholar
• Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364(10):897–906. doi:10.1056/NEJMoa1007285
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Lionetto L, Ricci A, Simmaco M, Borro M. Inter-individual variation in CYP2A6 activity and chronic obstructive pulmonary disease in smokers: perspectives for an early predictive marker. Biochim Biophys Acta Mol Basis Dis. 2021;1867(1):165990. doi:10.1016/j.bbadis.2020.165990
   PubMed Web of Science ®Google Scholar
• Lucattelli M, Bartalesi B, Cavarra E, et al. Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Respir Res. 2005;6(1):83. doi:10.1186/1465-9921-6-83
   PubMedGoogle Scholar
• Kinoshita Y, Watanabe K, Ishii H, Kushima H, Fujita M, Nabeshima K. Distribution of emphysema and fibrosis in idiopathic pulmonary fibrosis with coexisting emphysema. Histopathology. 2019;74(7):1103–1108. doi:10.1111/his.13831
   PubMed Web of Science ®Google Scholar
• Clinical Assembly contribution to the celebration of 20 years of the ERS, Balbi B, Cottin V, Singh S, et al. Smoking-related lung diseases: a clinical perspective. Eur Respir J. 2010;35(2):231–233. doi:10.1183/09031936.00189309
   PubMed Web of Science ®Google Scholar
• Morse D, Rosas IO. Tobacco smoke-induced lung fibrosis and emphysema. Annu Rev Physiol. 2014;76(1):493–513. doi:10.1146/annurev-physiol-021113-170411
   PubMedGoogle Scholar
• Weissmann N, Grimminger F, Seeger W. Smoking: is it a risk factor for pulmonary vascular diseases? Pulm Circ. 2012;2(4):395–396. doi:10.4103/2045-8932.105027
   PubMedGoogle Scholar
• Higenbottam T. Pulmonary hypertension and chronic obstructive pulmonary disease: a case for treatment. Proc Am Thorac Soc. 2005;2(1):12–19. doi:10.1513/pats.200411-053SF
   PubMedGoogle Scholar
• Santos S, Peinado VI, Ramirez J, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002;19(4):632–638. doi:10.1183/09031936.02.00245902
   PubMed Web of Science ®Google Scholar
• Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax. 2005;60(7):605–609. doi:10.1136/thx.2005.042994
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee DS, Kim EK, et al. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med. 2005;172(8):987–993. doi:10.1164/rccm.200501-041OC
   PubMed Web of Science ®Google Scholar
• Awano N, Inomata M, Ikushima S, et al. Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone. Histopathology. 2017;70(6):896–905. doi:10.1111/his.13153
   PubMed Web of Science ®Google Scholar
• Jacob J, Bartholmai BJ, Rajagopalan S, et al. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema. Respirology. 2018;23(6):593–599. doi:10.1111/resp.13231
   PubMed Web of Science ®Google Scholar
• Mitchell PD, Das JP, Murphy DJ, et al. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers. Respir Care. 2015;60(2):259–268. doi:10.4187/respcare.03389
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Carico E. Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: functional analysis. Clin Respir J. 2020;14(1):29–34. doi:10.1111/crj.13096
   PubMed Web of Science ®Google Scholar
• Behr J, Nathan SD, Harari S, et al. Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a Phase IIb, Randomised, Double-Blind, Placebo-Controlled Study - rationale and study design. Respir Med. 2018;138:13–20. doi:10.1016/j.rmed.2018.03.019
   PubMed Web of Science ®Google Scholar
• Jiang CG, Fu Q, Zheng CM. Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone. Ther Adv Respir Dis. 2019;13:1753466619888119. doi:10.1177/1753466619888119
   Web of Science ®Google Scholar
• Ryerson CJ, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013;144(1):234–240. doi:10.1378/chest.12-2403
   PubMed Web of Science ®Google Scholar
• Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003;167(7):962–969. doi:10.1164/rccm.2111053
   PubMed Web of Science ®Google Scholar
• Gao J, Kalafatis D, Carlson L, et al. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF registry. Respir Res. 2021;22(1):40. doi:10.1186/s12931-021-01634-x
   PubMed Web of Science ®Google Scholar
• Alakhras M, Decker PA, Nadrous HF, Collazo-Clavell M, Ryu JH. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest. 2007;131(5):1448–1453. doi:10.1378/chest.06-2784
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa021322
   PubMed Web of Science ®Google Scholar
• Moua T, Ryu JH. Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives. Ther Clin Risk Manag. 2019;15:73–81. doi:10.2147/TCRM.S160248
   PubMed Web of Science ®Google Scholar
• Romero F, Marchetti N, Hu A, et al. Efficacy of oral antifibrotic agents in the management of combined pulmonary fibrosis and emphysema. Am J Respir Crit Care Med. 2018;197:A1646.
   PubMed Web of Science ®Google Scholar
• King TE Jr., Bradford WZ, Castro-Bernardini S, et al. A Phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083–2092. doi:10.1056/NEJMoa1402582
   PubMed Web of Science ®Google Scholar
• Margaritopoulos GA, Trachalaki A, Wells AU, et al. Pirfenidone improves survival in IPF: results from a real-life study. BMC Pulm Med. 2018;18(1):177. doi:10.1186/s12890-018-0736-z
   PubMedGoogle Scholar
• Nathan SD, Albera C, Bradford WZ, et al. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Lancet Respir Med. 2017;5(1):33–41. doi:10.1016/S2213-2600(16)30326-5
   PubMed Web of Science ®Google Scholar
• Cottin V, Azuma A, Raghu G, et al. Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials. Eur Respir J. 2019;53(4). doi:10.1183/13993003.01655-2018
   Web of Science ®Google Scholar
• Yoon HY, Kim TH, Seo JB, et al. Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis. Respirology. 2019;24(1):55–62. doi:10.1111/resp.13387
   PubMed Web of Science ®Google Scholar